FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2016/12/007572 [Registered on: 14/12/2016] Trial Registered Retrospectively
Last Modified On: 15/11/2016
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Crossover Trial 
Public Title of Study   A clinical trial to compare the effect of two group of drugs while giving anesthesia in patients posted for major surgeries. 
Scientific Title of Study   Comparison of hemodynamic effects and ease of I-gel insertion with dexmedetomidine propofol vs fentanyl propofol 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Priyanka Dabas 
Designation  Postgraduate 
Affiliation  Kasturba Medical College, Mangalore 
Address  Kasturba Medical College , Post box no 53 , Light house hill road ,Mangalore
Katurba Medical College , Post box no 53 Light house hill road , Mangalore
Dakshina Kannada
KARNATAKA
575001
India 
Phone  9844619200  
Fax  8202571982  
Email  priyankadabas88@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Jitesh M Rasquinha 
Designation  Associate Professor 
Affiliation  Kasturba Medical College, Mangalore 
Address  Kasturba Medical College , Post box no 53 , Light house hill road , Mangalore
Katurba Medical College ,Post box no 53 ,Light house hill road , Mangalore
Dakshina Kannada
KARNATAKA
575001
India 
Phone  9845107528  
Fax  8202571982  
Email  dr_jitesh@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr Priyanka Dabas 
Designation  Postgraduate 
Affiliation  Kasturba Medical College Mangalore 
Address  Kasturba Medical College ,Post box no 53 ,Light house hill road , Mangalore
Kasturba Medical College ,Post box no 53 ,Light house hill road , Mangalore
Dakshina Kannada
KARNATAKA
575001
India 
Phone  9844619200  
Fax  8202571982  
Email  priyankadabas88@gmail.com  
 
Source of Monetary or Material Support  
Kasturba Medical College , Post box no 53 , Light house hill road, Mangalore 
 
Primary Sponsor  
Name  Priyanka Dabas 
Address  Flat no 402 , Vishwas manor appartment , Falnir , Mangalore 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Priyanka Dabas  Kasturba Medical College Hospital  Dept of anesthesiology,5 th floor, KMC hospital, Attavar , Mangalore
Dakshina Kannada
KARNATAKA 
9844619200
8202571982
priyankadabas88@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  ASA 1 and ASA 2 patients posted for surgery,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Comparator B : Fentanyl  Dose : 2 mcg per kg one dose Route : Intravenous , used before induction 
Comparator Agent  Comparator A : Dexmedetomidine   Dose : 2 mcg per kg one dose Route : Intravenous over 10 min used before induction . 
Intervention  Intervention : Propfol   Dose : 2 mg per kg one dose Route : Intravenous used for induction 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. ASA grade I & II.
2. 18-60 years of age.
3. Weight 35-80kgs.
4. Who gives informed written consent.
5. Patients scheduled to undergo elective surgical procedures .
 
 
ExclusionCriteria 
Details  1. Risk of gastric aspiration.
2. Patient who refuse for the study or have any known allergy.
3. Patients undergoing oral surgeries.
4. Those with Hepatic/ Renal/cardio-pulmonary abnormality, bleeding diathesis.
5. ASA grade III & IV patients.
 
 
Method of Generating Random Sequence   Stratified block randomization 
Method of Concealment   Other 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
• Heart rate, Respiratory rate ,Non invasive blood pressure and Oxygen saturation will be recorded before induction   Baseline, 30sec after induction, 1min, 3min,5min,10min and 15min after insertion of I-gel 
 
Secondary Outcome  
Outcome  TimePoints 
jaw mobility and coughing / bucking  2 optimum for i gel insertion 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Post Marketing Surveillance 
Date of First Enrollment (India)   18/02/2015 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   Not Yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   A randomized clinical trial : hemodynamic effects and ease of I gel insertion in dexmedetomidine - propofol vs propofol- fentanyl group with sample size of 40 in each group . total 80 cases ( ASA 1 and ASA 2 posted for elective surgery)  will be studied and their parameters will be assesed in terms of heart rate , o2 saturation , respiratory rate and blood pressure at different point of time before and after induction after giving respective drugs . ease of Igel insertion will be assesed as per their degree of jaw relaxation . Study hypothesis :
Introduction 
Aim
Objective 
Review of literature
materials and methods : study design 
                                             study setting 
                                            study population
                                            sample size
                                             inclusion criteria 
                                            exclusion criteria
                                             randomization 
                                             methodology
                                             study duration      
data analysis 
references
annexure 1 ( consent )
annexure 2 
annexure 3 ( patient performa )                                     

 
Close